$8075

80.75 (3.69%)

  • Open 78.53
  • High 80.83
  • Low 78.53
  • Vol 4,678,453
Stock, dividends & bonds

Investor kit

Download All
  • PMI Investor Information October 2020

    .pdf

    28/10/2020

  • 2019 Philip Morris International Inc. Annual Report

    .pdf

    26/03/2020

  • 2020 Proxy Statement

    .pdf

    26/03/2020

  • 2019 10-K

    .pdf

    07/02/2020

  • 2019 PMI Integrated Report—Fact Sheet

    .pdf

    06/07/2020

  • Q3 2020 10Q

    .pdf

    27/10/2020

nick_rolli
We built the world's most successful cigarette company. Now we're building our future on smoke-free products that are a much better choice than smoking.
Nicholas Rolli, Vice President Investor Relations

Why invest in PMI?

Philip Morris International is leading a transformation in the tobacco industry to create a smoke-free future, and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, as well as to society, the company, and its shareholders. PMI is building its future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its products meet adult consumer preferences and rigorous regulatory requirements.

thumbnail-ir-video0cda1abd6c7468f696e2ff0700458fff
ginza-store

Global market profile

We are engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in more than 180 markets outside the United States of America.
Who we are

An unparalleled portfolio of brands

Our brand portfolio is led by Marlboro, the world’s best-selling international cigarette. Our leading reduced-risk product, IQOS, is typically marketed with heated tobacco units under the brand names HEETS or Marlboro HeatSticks. Based on the strength of our brand portfolio, we enjoy robust pricing power.

 

Banner_Heated-tobacco
scienceinnovation-half-image

Leading-edge research and development

One of our key strategic priorities is to develop, assess, and commercialize a portfolio of innovative tobacco and other nicotine-containing products. We draw on the expertise of a team of world-class scientists from a broad spectrum of disciplines to help us reach our ultimate goal of replacing cigarettes with less harmful alternatives.
Our science

 

Delivering a smoke-free future in a sustainable way

Replacing cigarettes with less harmful alternatives is at the core of our business strategy, and sits atop our sustainability priorities. Find out more about PMIs transformation, and our approach to sustainability.

 

*Reduced Risk Products (RRPs) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking.  PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.